IL17A and psoriasis vulgaris: Since IL-17 levels were similar but its downstream pathway product levels were different within non-lesional skin of thick and thin plaque psoriasis, we hypothesized that systemic inflammatory differences may exist between the subtypes and further analyzed the expression of circulating cytokines and other inflammatory factors in blood.